<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2024-1-107-116</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2300</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Динамика структурно-функциональных параметров у пациентов с сухой формой ВМД после каскадной плазмофильтрации</article-title><trans-title-group xml:lang="en"><trans-title>Dynamics of Structural and Functional Changes of Patients with Dry Form Age-related Macular Degeneration after Double Filtration Plasmapheresis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5446-5063</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воложев</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Volozhev</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воложев Александр Аркадьевич — адъюнкт кафедры офтальмологии им. профессора В.В. Волкова</p><p>ул. Академика Лебедева, 6, Санкт-Петербург, 194044</p></bio><bio xml:lang="en"><p>Volozhev Aleksandr A. — adjunct of the Ophthalmology department named after professor V.V. Volkov</p><p>Academician Lebedev str., 6, Saint Petersburg, 194044</p></bio><email xlink:type="simple">aleksandr-volozh@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5274-6993</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликов</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куликов Алексей Николаевич — доктор медицинских наук, профессор, начальник кафедры (клиники) офтальмологии им. профессора В.В. Волкова</p><p>ул. Академика Лебедева, 6, Санкт-Петербург, 194044</p></bio><bio xml:lang="en"><p>Kulikov Aleksey N. — MD, Professor, head of the Ophthalmology department named after professor V.V. Volkov</p><p>Academician Lebedev str., 6, Saint Petersburg, 194044</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0421-3797</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бельских</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Belskih</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бельских Андрей Николаевич — доктор медицинских наук, профессор, член-корреспондент РАН, заведующий кафедрой нефрологии и эфферентной терапии</p><p>ул. Академика Лебедева, 6, Санкт-Петербург, 194044</p></bio><bio xml:lang="en"><p>Belskih Andrey N. — MD, Professor, Corresponding Member of the Russian Academy of Sciences, head of the Nephrology and Blood Purification department</p><p>Academician Lebedev str., 6, Saint Petersburg, 194044</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6598-3982</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мальцев</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Maltsev</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мальцев Дмитрий Сергеевич — доктор медицинских наук, профессор кафедры офтальмологии им. профессора В.В. Волкова</p><p>ул. Академика Лебедева, 6, Санкт-Петербург, 194044</p></bio><bio xml:lang="en"><p>Maltsev Dmitrii S. — MD, Professor of the Ophthalmology department named after Professor V.V. Volkov</p><p>Academician Lebedev str., 6, Saint Petersburg, 194044</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-3960-7346</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беднова</surname><given-names>С. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Bednova</surname><given-names>S. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Беднова Светлана Евгеньевна — врач клиники нефрологии и эфферентной терапии</p><p>ул. Академика Лебедева, 6, Санкт-Петербург, 194044</p></bio><bio xml:lang="en"><p>Bednova Svetlana E. — researcher, of the Nephrology and blood purification department</p><p>Academician Lebedev str., 6, Saint Petersburg, 194044</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9596-5504</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николаенко</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolaenko</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Николаенко Евгения Николаевна — кандидат медицинских наук, врач клиники офтальмологии</p><p>ул. Академика Лебедева, 6, Санкт-Петербург, 194044</p></bio><bio xml:lang="en"><p>Nikoaenko Evgeniia N. — PhD, ophthalmologist of the Ophthalmology department named after Professor V.V. Volkov</p><p>Academician Lebedev str., 6, Saint Petersburg, 194044</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Министерства обороны Российской Федерации<country>Россия</country></aff><aff xml:lang="en">S.M. Kirov Military Medical Academy<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>31</day><month>03</month><year>2024</year></pub-date><volume>21</volume><issue>1</issue><fpage>107</fpage><lpage>116</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воложев А.А., Куликов А.Н., Бельских А.Н., Мальцев Д.С., Беднова С.Е., Николаенко Е.Н., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Воложев А.А., Куликов А.Н., Бельских А.Н., Мальцев Д.С., Беднова С.Е., Николаенко Е.Н.</copyright-holder><copyright-holder xml:lang="en">Volozhev A.A., Kulikov A.N., Belskih A.N., Maltsev D.S., Bednova S.E., Nikolaenko E.N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2300">https://www.ophthalmojournal.com/opht/article/view/2300</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Одним из социально значимых офтальмологических заболеваний является сухая форма возрастной макулярной дегенерации (сВМД). Ключевая особенность сВМД — медленно прогрессирующее повреждение пигментного эпителия и формирование друз, однако базовые механизмы патогенеза в настоящее время остаются не до конца изученными. Факторы риска сВМД включают возраст, наследственность, образ жизни и другие вызывающие нарушение обмена веществ сдвиги гемореологических показателей, способствующие активации процессов друзогенеза, неоангиогенеза. Исходом сВМД является географическая атрофия пигментного эпителия сетчатки и хориокапиллярного слоя, сопровождающаяся потерей центрального зрения. Высокоэффективным методом коррекции метаболических и реологических нарушений, применяемым в нашей стране, является каскадная плазмофильтрация (КПФ). Ее применение у пациентов с сВМД является патогенетически аргументированным, но в доступной литературе корректный анализ эффективности и безопасности применения каскадной плазмофильтрации у пациентов с промежуточной стадией сВМД представлен единичными публикациями.</p></sec><sec><title>Цель</title><p>Цель: изучить по данным ОКТ, ОКТангиографии, визометрии, микропериметрии и электроретинографии динамику структурно-функциональных параметров макулярной зоны у пациентов с сухой формой возрастной макулярной дегенерации после применения каскадной плазмофильтрации.</p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы. В исследование были включены 63 пациента (94 глаза) с промежуточной стадией сВМД. Пациенты случайным образом были разделены на две группы. В первую группу (основную) вошли 34 пациента (52 глаза), которым выполняли КПФ с помощью аппарата OctoNova с использованием плазмофильтра Plasmaflo и фракционатора Cascadeflo EC40 в количестве 4 процедур с периодичностью 1 раз в неделю в течение 1 месяца. Во вторую группу (контрольную) вошли 29 пациентов (42 глаза), которые не получали какого-либо специфического лечения. Пациентам основной группы до курса КПФ, после курса КПФ (через 1 месяц от начала наблюдения), через 6 и 12 месяцев наряду со стандартным офтальмологическим обследованием дополнительно проводили ОКТ, ОКТ-ангиографию, микропериметрию и электроретинографию. Пациентам контрольной группы аналогичное обследование также выполняли в указанные сроки — через 1, 6, 12 месяцев от начала наблюдения.</p></sec><sec><title>Результаты</title><p>Результаты. Было выявлено, что по данным оптической когерентной томографии, оптической когерентной томографии-ангиографии, визометрии, микропериметрии и электроретинографии наблюдается положительная динамика структурно-функциональных показателей макулярной сетчатки на фоне применения каскадной плазмофильтрации в лечении пациентов с сухой формой ВМД. При этом статистически значимая разница между двумя группами начиналась с 1 месяца и сохранялась до 12 месяца наблюдения, что указывает на стабилизацию патологического процесса в течение указанного срока.</p></sec><sec><title>Заключение</title><p>Заключение. Было показано, что после применения каскадной плазмофильтрации у пациентов с сухой формой возрастной макулярной дегенерации наблюдается улучшение структурно-функциональных показателей макулярной зоны, заключающееся в уменьшении объема ДОПЭС и стабилизации светочувствительности сетчатки.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Actuality</title><p>Actuality. One of the significant ophthalmic diseases is a dry form age-related macular degeneration (dAMD). The issues of etiology and pathogenesis are not completely cleared nowadays and they signify the subject of discussion. There are risk factors of dAMD (age, heredity, lifestyle etc.) which can cause metabolic disorders, changes hemorheological parameters which promote activation of druseogenesis and as a result an angiogenesis. Mostly an outcome of dAMD is geographical atrophy and decrease of central visual acuity. At the same time, it is known that similar metabolic and rheological disorders detected in other diseases are effectively corrected by extracorporeal rheoaferesis, in particular, using double filtration plasmapheresis. Thus, using of extracorporeal rheoaferesis with dAMD patients is pathogenetically well-reasoned, but in the available literature, a correct analysis of the effectiveness and safety of double filtration plasmapheresis in patients with intermediate stage of dAMD is presented poorly.</p></sec><sec><title>Objective</title><p>Objective. To study along with data of OCT, OCT angiography, visometry, microperimetry and electroretinography structural and functional changes in the macular zone in patients with a dry form of age-related macular degeneration after the using of double filtration plasmapheresis.</p></sec><sec><title>Patients and methods</title><p>Patients and methods. The study included 63 patients (94 eyes) with an intermediate stage of dAMD. The patients were separated into two groups randomly. The first (main) group included 34 patients (52 eyes) who were performed double filtration plasmapheresis (DFPP) on an OctoNova device using a Plasmaflo plasma filter and a Cascadeflo EC40 fractionator in the amount of 4 procedures with a frequency of 1 time per week for 1 month. The second group (control) included 29 patients (42 eyes) who did not receive any specific treatment. In the main group of patients, OCT, OCT angiography, microperimetry and electroretinography were additionally performed in addition to standard ophthalmological examination before the DFPP course, after the DFPP course (1 month after the start of follow-up), 6 and 12 months later. Patients in the control group also underwent a similar examination at the specified time — 1, 6, 12 months after the start of follow-up.</p></sec><sec><title>Results</title><p>Results. In this study we found according to optical coherence tomography, optical coherence tomography-angiography, visometry, microperimetry and electroretinography, positive dynamics of structural and functional parameters of the macular retina is observed in patients with a dry form of age-related macular degeneration with using double filtration plasmapheresis. At the same time, a statistically significant difference between the two groups begins at 1 month and persists for 12 months of follow-up, which points to stabilization of the pathological process during the specified period.</p></sec><sec><title>Conclusions</title><p>Conclusions. This study showed that after applying the double filtration plasmapheresis in patients with dry form of age-related macular degeneration, there is an improvement in structural and functional parameters of the macular zone, consisting in a decrease volume DOPES and stabilization of retinal light sensitivity.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>возрастная макулярная дегенерация</kwd><kwd>лечение сухой формы ВМД</kwd><kwd>каскадная плазмофильтрация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>age-related macular degeneration</kwd><kwd>treatment of dry AMD</kwd><kwd>double filtration plasmapheresis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Измайлов АС. Лечение «сухой» формы возрастной макулярной дегенерации. РМЖ «Клиническая Офтальмология». 2017;1:56–60. doi: 10.21689/2311-7729-2017-17-1-56-60.</mixed-citation><mixed-citation xml:lang="en">Izmaylov AS. Treatment of a “dry” form of age-related macular degeneration. Russian Medical Journal. Clinical Ophthalmology. 2017;1:56–60 (In Russ.). doi: 10.21689/2311-7729-2017-17-1-56-60.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Donders FC. Beiträge zur pathologischen Anatomie des Auges. Contributions to the pathologic anatomy of the eye. Archiv für Ophthalmologie. 1855;106–118.</mixed-citation><mixed-citation xml:lang="en">Donders FC. Beiträge zur pathologischen Anatomie des Auges. Contributions to the pathologic anatomy of the eye. Archiv für Ophthalmologie. 1855;106–118.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hutchinson J. Symmetrical central choroido-retinal disease occurring in senile persons. The Royal London Ophthalmic Hospital records and journal of ophthalmic medicine and surgery. 1874;231–244.</mixed-citation><mixed-citation xml:lang="en">Hutchinson J. Symmetrical central choroido-retinal disease occurring in senile persons. The Royal London Ophthalmic Hospital records and journal of ophthalmic medicine and surgery. 1874;231–244.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Haab O. Erkrankungen der Macula lutea. Disaes of the macula lutea. Centralblat für praktische Augenheilkunde. 1885;384–391.</mixed-citation><mixed-citation xml:lang="en">Haab O. Erkrankungen der Macula lutea. Disaes of the macula lutea. Centralblat für praktische Augenheilkunde. 1885;384–391.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Haab O. Atlas und Grundriss der Ophthalmoskopie und ophthalmoskopischen Diagnostik. Atlas and outline of ophthalmoscopy and ophthalmoskopic diagnostics. Lehmann: München, 1908;2.</mixed-citation><mixed-citation xml:lang="en">Haab O. Atlas und Grundriss der Ophthalmoskopie und ophthalmoskopischen Diagnostik. Atlas and outline of ophthalmoscopy and ophthalmoskopic diagnostics. Lehmann: München, 1908;2.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973 Sep;90(3):206–217. doi: 10.1001/archopht.1973.01000050208006.</mixed-citation><mixed-citation xml:lang="en">Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973 Sep;90(3):206–217. doi: 10.1001/archopht.1973.01000050208006.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Либман ЕС, Шахова ЕВ. Слепота и инвалидность вследствие патологии органа зрения в России. Вестник офтальмологии. 2006;122(1):209–214.</mixed-citation><mixed-citation xml:lang="en">Liebman ES, Shakhova EV. Blindness and disability due to pathology of the organ of vision in Russia. The Russian Annals of Ophthalmology. 2006;122(1):209–2014 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Коняев ДА, Попова ЕВ, Титов АА, Агарков НМ, Яблоков ММ, Аксёнов ВВ. Распространённость заболеваний глаза у пожилых — глобальная проблема современности. Здравоохранение Российской Федерации. 2021;65(1):62–68. doi: 10.47470/0044-197X-2021-65-1-62-68.</mixed-citation><mixed-citation xml:lang="en">Konyaev DA, Popova EB, Titov AA, Agarkov NM, Yablokov MM, Aksenov VV. The prevalence of eye diseases in the elderly population is a global problem of modernity. Health care of the Russian Federation. 2021;65(1):62–68 (In Russ.). doi: 10.47470/0044-197X-2021-65-1-62-68.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Stahl A. The Diagnosis and Treatment of Age-Related Macular Degeneration. Dtsch Arztebl Int. 2020 Jul 20;117(29–30):513–520. doi: 10.3238/arztebl.2020.0513.</mixed-citation><mixed-citation xml:lang="en">Stahl A. The Diagnosis and Treatment of Age-Related Macular Degeneration. Dtsch Arztebl Int. 2020 Jul 20;117(29–30):513–520. doi: 10.3238/arztebl.2020.0513.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014 Feb;2(2):e106–116. doi: 10.1016/S2214-109X(13)70145-1.</mixed-citation><mixed-citation xml:lang="en">Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020  and 2040: a  systematic review and meta-analysis. Lancet Glob Health. 2014 Feb;2(2):e106–116. doi: 10.1016/S2214-109X(13)70145-1.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Roh M, Laíns I, Shin HJ, Park DH, Mach S, Vavvas DG, Kim IK, Miller JW, Husain D, Miller JB. Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography. Br J Ophthalmol. 2019 Dec;103(12):1769–1776. doi: 10.1136/bjophthalmol-2018-313316.</mixed-citation><mixed-citation xml:lang="en">Roh M, Laíns I, Shin HJ, Park DH, Mach S, Vavvas DG, Kim IK, Miller JW, Husain D, Miller JB. Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography. Br J Ophthalmol. 2019 Dec;103(12):1769–1776. doi: 10.1136/bjophthalmol-2018-313316.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson PT, Lewis JP, Talaga KC, Brown MN, Kappel PJ, Fisher SK, Anderson DH, Johnson LV. Drusen-Associated Degeneration in the Retina. Invest. Ophthalmol. Vis. Sci. 2003;44(10):4481–4488.</mixed-citation><mixed-citation xml:lang="en">Johnson PT, Lewis JP, Talaga KC, Brown MN, Kappel PJ, Fisher SK, Anderson DH, Johnson LV. Drusen-Associated Degeneration in the Retina. Invest. Ophthalmol. Vis. Sci. 2003;44(10):4481–4488.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">De Jong PTVM. Elusive drusen and changing terminology of AMD. Eye (Lond). 2018 May;32(5):904–914. doi: 10.1038/eye.2017.298.</mixed-citation><mixed-citation xml:lang="en">De Jong PTVM. Elusive drusen and changing terminology of AMD. Eye (Lond). 2018 May;32(5):904–914. doi: 10.1038/eye.2017.298.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Мануилов АС, Бардаков СН, Апчел АВ, Бельских АН, Захаров МВ, Тишко ВВ, Иванов АМ. Опыт применения каскадной плазмофильтрации в комбинированном лечении системной красной волчанки на фоне программного гемодиализа. Вестник Российской Военно-медицинской академии. 2018;20(2):115–119. doi: 10.17816/brmma12278.</mixed-citation><mixed-citation xml:lang="en">Manuilov AS, Bardakov SN, Apchel AV, Belskih AN, Zakharov MV, Tishko VV, Ivanov AM. The experience of using cascade plasmofiltration in combined treatment with systemic lupus erythematosus on the background of programmed hemodialysis. Bulletin of the Russian Military Medical Academy. 2018;20(2):115–119 (In Russ.). doi: 10.17816/brmma12278.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W; AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 1;140(7):692–698. doi: 10.1001/jamaophthalmol.2022.1640.</mixed-citation><mixed-citation xml:lang="en">Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W; AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3  Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 1;140(7):692–698. doi: 10.1001/jamaophthalmol.2022.1640.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Z, Deng KY, Deng YM, Hui YN, Song YP. Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study. Int J Ophthalmol. 2022 Mar 18;15(3):474–482. doi: 10.18240/ijo.2022.03.16.</mixed-citation><mixed-citation xml:lang="en">Huang Z, Deng KY, Deng YM, Hui YN, Song YP. Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a  preliminary clinical study. Int J  Ophthalmol. 2022 Mar 18;15(3):474–482. doi: 10.18240/ijo.2022.03.16.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, McGuinness MB, Fletcher EL, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Lek JJ, Harper CA, Wickremasinghe SS, Sandhu SS, Baglin EK, Sharangan P, Braat S, Luu CD. Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group. Subthreshold Nanosecond Laser Intervention in AgeRelated Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. Ophthalmology. 2019 Jun;126(6):829–838. doi: 10.1016/j.ophtha.2018.09.015.</mixed-citation><mixed-citation xml:lang="en">Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, McGuinness MB, Fletcher EL, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Lek JJ, Harper CA, Wickremasinghe SS, Sandhu SS, Baglin EK, Sharangan P, Braat S, Luu CD. Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group. Subthreshold Nanosecond Laser Intervention in AgeRelated Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. Ophthalmology. 2019 Jun;126(6):829–838. doi: 10.1016/j.ophtha.2018.09.015.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Brunner R, Widder RA, Walter P, Luke C, Godehardt E, € Bartz-Schmidt K-U, et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration––a randomized trial. Retina. 2000;20:483–491.</mixed-citation><mixed-citation xml:lang="en">Brunner R, Widder RA, Walter P, Luke C, Godehardt E, € Bartz-Schmidt K-U, et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration––a randomized trial. Retina. 2000;20:483–491.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Swartz M, Rabetoy G. Treatment of non-exudative agerelated macular degeneration using membrane differential filtration apheresis. Invest Ophthalmol Vis Sci. 1999;40:319.</mixed-citation><mixed-citation xml:lang="en">Swartz M, Rabetoy G. Treatment of non-exudative agerelated macular degeneration using membrane differential filtration apheresis. Invest Ophthalmol Vis Sci. 1999;40:319.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Klingel R, Fassbender C, Heibges A, Koch F, Nasemann J, Engelmann K, Carl T, Meinke M, Erdtracht B. RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration. Ther Apher Dial. 2010 Jun;14(3):276–286. doi: 10.1111/j.1744-9987.2010.00807.x.</mixed-citation><mixed-citation xml:lang="en">Klingel R, Fassbender C, Heibges A, Koch F, Nasemann J, Engelmann K, Carl T, Meinke M, Erdtracht B. RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration. Ther Apher Dial. 2010 Jun;14(3):276–286. doi: 10.1111/j.1744-9987.2010.00807.x.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
